PAR paradigm biopharmaceuticals limited..

New orphan drug designation, page-8

  1. 2,443 Posts.
    lightbulb Created with Sketch. 293
    Yeah still need to run trials and submit all the evidence etc. The designation speeds the approval status up though and there are tax benefits and exclusivity benefits.

    Still coming up to speed with all this so DYOR

    PharmD
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.0¢
Change
-0.010(2.38%)
Mkt cap ! $162.9M
Open High Low Value Volume
42.0¢ 42.3¢ 39.5¢ $453.0K 1.114M

Buyers (Bids)

No. Vol. Price($)
1 49347 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 70000 2
View Market Depth
Last trade - 16.10pm 17/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.